ROV
nevanimibe
| Created: | 2020-02-18 |
| Last modified: | 2020-06-05 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 70 |
| Chiral Atom Count | 0 |
| Bond Count | 72 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | nevanimibe |
| Synonyms | N-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-N'-[2,6-di(propan-2-yl)phenyl]urea |
| Systematic Name (OpenEye OEToolkits) | 1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea |
| Formula | C27 H39 N3 O |
| Molecular Weight | 421.618 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | C(C)(C)c1c(c(C(C)C)ccc1)NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C |
| SMILES | CACTVS | 3.385 | CC(C)c1cccc(C(C)C)c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C |
| SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)c1cccc(c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C)C(C)C |
| Canonical SMILES | CACTVS | 3.385 | CC(C)c1cccc(C(C)C)c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)c1cccc(c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C)C(C)C |
| InChI | InChI | 1.03 | InChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31) |
| InChIKey | InChI | 1.03 | PKKNCEXEVUFFFI-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB16254 |
|---|---|
| Name | Nevanimibe |
| Description | Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome). |
| Synonyms |
|
| Categories | Amides |
| CAS number | 133825-80-6 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 131679 |
| ChEMBL | CHEMBL46423 |














